A detailed history of Petra Financial Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Petra Financial Advisors Inc holds 1,678 shares of LLY stock, worth $1.26 Million. This represents 0.98% of its overall portfolio holdings.

Number of Shares
1,678
Previous 1,742 3.67%
Holding current value
$1.26 Million
Previous $1.58 Billion 5.76%
% of portfolio
0.98%
Previous 1.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$772.14 - $960.02 $49,416 - $61,441
-64 Reduced 3.67%
1,678 $1.49 Billion
Q2 2024

Jul 18, 2024

SELL
$724.87 - $909.04 $4,349 - $5,454
-6 Reduced 0.34%
1,742 $1.58 Billion
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $283,071 - $378,709
478 Added 37.64%
1,748 $1.33 Billion
Q4 2023

Jan 29, 2024

BUY
$525.19 - $619.13 $135,499 - $159,735
258 Added 25.49%
1,270 $740 Million
Q3 2023

Nov 01, 2023

BUY
$434.7 - $599.3 $439,916 - $606,491
1,012 New
1,012 $544 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $713B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Petra Financial Advisors Inc Portfolio

Follow Petra Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petra Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Petra Financial Advisors Inc with notifications on news.